Roivant Sciences Financials

Roivant Sciences Stock Summary

Roivant Sciences competes with Roivant Sciences, Jasper Therapeutics, and Humacyte. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 620 people.

Roivant Sciences Key Financial Ratios

Roivant Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Roivant Sciences's current stock value. Our valuation model uses many indicators to compare Roivant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roivant Sciences competition to find correlations between indicators driving Roivant Sciences's intrinsic value. More Info.Roivant Sciences is rated second in operating margin category among its peers. It also is rated second in number of shares shorted category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Roivant Sciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.